These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 30328797)

  • 41. IL-23: a promising therapeutic target for systemic lupus erythematosus.
    Leng RX; Pan HF; Chen GM; Wang C; Qin WZ; Chen LL; Tao JH; Ye DQ
    Arch Med Res; 2010 Apr; 41(3):221-5. PubMed ID: 20682181
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Curcumin inhibits experimental allergic encephalomyelitis by blocking IL-12 signaling through Janus kinase-STAT pathway in T lymphocytes.
    Natarajan C; Bright JJ
    J Immunol; 2002 Jun; 168(12):6506-13. PubMed ID: 12055272
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sphingosine-1-phosphate differently regulates the cytokine production of IL-12, IL-23 and IL-27 in activated murine bone marrow derived dendritic cells.
    Schaper K; Kietzmann M; Bäumer W
    Mol Immunol; 2014 May; 59(1):10-8. PubMed ID: 24434636
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of IL-23p19 as an endothelial proinflammatory peptide that promotes gp130-STAT3 signaling.
    Espígol-Frigolé G; Planas-Rigol E; Ohnuki H; Salvucci O; Kwak H; Ravichandran S; Luke B; Cid MC; Tosato G
    Sci Signal; 2016 Mar; 9(419):ra28. PubMed ID: 26980441
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Potential role of Mycoplasma hominis in interleukin (IL)-17-producing CD4+ T-cell generation via induction of IL-23 secretion by human dendritic cells.
    Truchetet ME; Beven L; Renaudin H; Douchet I; Férandon C; Charron A; Blanco P; Schaeverbeke T; Contin-Bordes C; Bébéar C
    J Infect Dis; 2011 Dec; 204(11):1796-805. PubMed ID: 21971287
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Transcriptional network profile on synovial fluid T cells in psoriatic arthritis.
    Fiocco U; Martini V; Accordi B; Caso F; Costa L; Oliviero F; Scanu A; Facco M; Boso D; Gatto M; Felicetti M; Frallonardo P; Ramonda R; Piva L; Zambello R; Agostini C; Scarpa R; Basso G; Semenzato G; Dayer JM; Punzi L; Doria A
    Clin Rheumatol; 2015 Sep; 34(9):1571-80. PubMed ID: 26152611
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical and Histopathological Amelioration of Experimental Autoimmune Encephalomyelitis by AAV Vectors Expressing a Soluble Interleukin-23 Receptor.
    Miralles M; Eixarch H; Tejero M; Costa C; Hirota K; Castaño AR; Puig M; Stockinger G; Montalban X; Bosch A; Espejo C; Chillon M
    Neurotherapeutics; 2017 Oct; 14(4):1095-1106. PubMed ID: 28593439
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interleukin-23-Dependent γ/δ T Cells Produce Interleukin-17 and Accumulate in the Enthesis, Aortic Valve, and Ciliary Body in Mice.
    Reinhardt A; Yevsa T; Worbs T; Lienenklaus S; Sandrock I; Oberdörfer L; Korn T; Weiss S; Förster R; Prinz I
    Arthritis Rheumatol; 2016 Oct; 68(10):2476-86. PubMed ID: 27111864
    [TBL] [Abstract][Full Text] [Related]  

  • 49. IFN-beta inhibits human Th17 cell differentiation.
    Ramgolam VS; Sha Y; Jin J; Zhang X; Markovic-Plese S
    J Immunol; 2009 Oct; 183(8):5418-27. PubMed ID: 19783688
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inflammation and atherosclerosis: a review of the role of interleukin-6 in the development of atherosclerosis and the potential for targeted drug therapy.
    Hartman J; Frishman WH
    Cardiol Rev; 2014; 22(3):147-51. PubMed ID: 24618929
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A unique role for IL-23 in promoting cellular immunity.
    Lankford CS; Frucht DM
    J Leukoc Biol; 2003 Jan; 73(1):49-56. PubMed ID: 12525561
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthesis of benzoxazole derivatives as interleukin-6 antagonists.
    Kim D; Won HY; Hwang ES; Kim YK; Choo HP
    Bioorg Med Chem; 2017 Jun; 25(12):3127-3134. PubMed ID: 28442260
    [TBL] [Abstract][Full Text] [Related]  

  • 53. IL-23/IL-17 biology and therapeutic considerations.
    Dong C
    J Immunotoxicol; 2008 Jan; 5(1):43-6. PubMed ID: 18382857
    [TBL] [Abstract][Full Text] [Related]  

  • 54. p19-targeted ABD-derived protein variants inhibit IL-23 binding and exert suppressive control over IL-23-stimulated expansion of primary human IL-17+ T-cells.
    Křížová L; Kuchař M; Petroková H; Osička R; Hlavničková M; Pelák O; Černý J; Kalina T; Malý P
    Autoimmunity; 2017 Mar; 50(2):102-113. PubMed ID: 28100093
    [TBL] [Abstract][Full Text] [Related]  

  • 55. IL-23 is increased in dendritic cells in multiple sclerosis and down-regulation of IL-23 by antisense oligos increases dendritic cell IL-10 production.
    Vaknin-Dembinsky A; Balashov K; Weiner HL
    J Immunol; 2006 Jun; 176(12):7768-74. PubMed ID: 16751425
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nickel Sulfate Promotes IL-17A Producing CD4+ T Cells by an IL-23-Dependent Mechanism Regulated by TLR4 and Jak-STAT Pathways.
    Bechara R; Antonios D; Azouri H; Pallardy M
    J Invest Dermatol; 2017 Oct; 137(10):2140-2148. PubMed ID: 28634033
    [TBL] [Abstract][Full Text] [Related]  

  • 57. IL-17 and Th17 cells in atherosclerosis: subtle and contextual roles.
    Taleb S; Tedgui A; Mallat Z
    Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):258-64. PubMed ID: 25234818
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthetic Deletion of the Interleukin 23 Receptor (IL-23R) Stalk Region Led to Autonomous IL-23R Homodimerization and Activation.
    Hummel TM; Ackfeld T; Schönberg M; Ciupka G; Schulz F; Oberdoerster A; Grötzinger J; Scheller J; Floss DM
    Mol Cell Biol; 2017 Sep; 37(17):. PubMed ID: 28630278
    [TBL] [Abstract][Full Text] [Related]  

  • 59. IL-2 activation of STAT5 enhances production of IL-10 from human cytotoxic regulatory T cells, HOZOT.
    Tsuji-Takayama K; Suzuki M; Yamamoto M; Harashima A; Okochi A; Otani T; Inoue T; Sugimoto A; Motoda R; Yamasaki F; Nakamura S; Kibata M
    Exp Hematol; 2008 Feb; 36(2):181-92. PubMed ID: 18023521
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cutting edge: IL-12 induces CD4+CD25- T cell activation in the presence of T regulatory cells.
    King IL; Segal BM
    J Immunol; 2005 Jul; 175(2):641-5. PubMed ID: 16002658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.